Your browser doesn't support javascript.
Olfactory function and viral recovery in COVID-19.
Mazzoli, Marco; Molinari, Maria Angela; Tondelli, Manuela; Giovannini, Giada; Ricceri, Riccardo; Ciolli, Ludovico; Picchetto, Livio; Meletti, Stefano.
  • Mazzoli M; Neurology Unit, OCB Hospital, Azienda Ospedaliera-Universitaria, Modena, Italy.
  • Molinari MA; Department of Biomedical, Metabolic and Neural Science, University of Modena and Reggio Emilia, Modena, Italy.
  • Tondelli M; Neurology Unit, OCB Hospital, Azienda Ospedaliera-Universitaria, Modena, Italy.
  • Giovannini G; Azienda USL, Modena, Italy.
  • Ricceri R; Neurology Unit, OCB Hospital, Azienda Ospedaliera-Universitaria, Modena, Italy.
  • Ciolli L; Department of Biomedical, Metabolic and Neural Science, University of Modena and Reggio Emilia, Modena, Italy.
  • Picchetto L; Neurology Unit, OCB Hospital, Azienda Ospedaliera-Universitaria, Modena, Italy.
  • Meletti S; Neurology Unit, OCB Hospital, Azienda Ospedaliera-Universitaria, Modena, Italy.
Brain Behav ; 11(3): e02006, 2021 03.
Article in English | MEDLINE | ID: covidwho-1059639
ABSTRACT

BACKGROUND:

Olfactory and taste disorders were reported in up to 30%-80% of COVID-19 patients. The purpose of our study was to objectively assess smell impairment in COVID-19 patients and to correlate olfactory function with viral recovery.

METHODS:

Between 15 and 30 April 2020, hospitalized patients with confirmed SARS-CoV-2 infection underwent an objective assessment of olfactory function with the Smell Identification subtest of the Sniffin' Sticks Test (SI-SST). Association between viral recovery and SI-SST performance was evaluated.

RESULTS:

51 patients were enrolled (49% males, mean age 66.2 ± 14.6 years). At the time of test administration, 45% were clinically recovered and 39% were virus-free. Objective hyposmia/anosmia was found in 45% of the patients. Subjective olfactory disorders showed no association with the clinical or viral recovery status of the patients. On the contrary, none of the patients with anosmia and the 5% of hyposmic patients at test had viral recovery. The relative risk for hyposmic patients to be still positive at swab test was 10.323 (95% CI 1.483-71.869, p < .0001). Logistic regression analysis showed an independent and significant correlation between viral clearance and SI-SST scores (OR = 2.242; 95% CI 1.322-3.802, p < .003). ROC curve analysis confirmed that a SI-SST > 10.5 predicts viral clearance with 79% sensitivity and 87% specificity (AUC = 0.883).

CONCLUSION:

Hyposmia is part of COVID-19 symptoms; however, only objectively assessed olfactory function is associated with viral recovery. SI-SST is an easy and safe instrument, and further large multicentric studies should assess its value to predict infection and recovery.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Smell / SARS-CoV-2 / COVID-19 / Olfaction Disorders Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: English Journal: Brain Behav Year: 2021 Document Type: Article Affiliation country: Brb3.2006

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Smell / SARS-CoV-2 / COVID-19 / Olfaction Disorders Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: English Journal: Brain Behav Year: 2021 Document Type: Article Affiliation country: Brb3.2006